|
LSM14A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.090650E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.820580E-03 |
| Normal-vs-Stage2 |
3.898800E-01 |
| Normal-vs-Stage3 |
7.616600E-01 |
| Normal-vs-Stage4 |
2.125800E-01 |
| Stage1-vs-Stage2 |
4.148000E-01 |
| Stage1-vs-Stage3 |
2.022100E-03 |
| Stage1-vs-Stage4 |
8.21650000000229E-05 |
| Stage2-vs-Stage3 |
3.094200E-01 |
| Stage2-vs-Stage4 |
1.136200E-01 |
| Stage3-vs-Stage4 |
3.752600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.475700E-02 |
| Normal-vs-AfricanAmerican |
8.957800E-01 |
| Normal-vs-Asian |
3.215700E-02 |
| Caucasian-vs-AfricanAmerican |
2.522800E-01 |
| Caucasian-vs-Asian |
3.157400E-01 |
| AfricanAmerican-vs-Asian |
1.452150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.835400E-01 |
| Normal-vs-Female |
1.916190E-02 |
| Male-vs-Female |
7.780000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.454200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.164500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.244000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.413200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.257600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.887800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.033400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.670370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.539210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.142800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.09889999999613E-06 |
| Normal-vs-Grade 2 |
3.587600E-04 |
| Normal-vs-Grade 3 |
8.345400E-01 |
| Normal-vs-Grade 4 |
1.737790E-02 |
| Grade 1-vs-Grade 2 |
3.376400E-02 |
| Grade 1-vs-Grade 3 |
1.432140E-04 |
| Grade 1-vs-Grade 4 |
8.71779999966904E-07 |
| Grade 2-vs-Grade 3 |
2.637300E-04 |
| Grade 2-vs-Grade 4 |
8.17449999912512E-08 |
| Grade 3-vs-Grade 4 |
9.195100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.59329999088942E-09 |
| Normal-vs-ccB subtype |
5.062000E-02 |
| ccA subtype-vs-ccB subtype |
5.10702591327572E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.033400E-01 |
| Normal-vs-N1 |
7.584400E-01 |
| N0-vs-N1 |
4.459400E-01 |
|
|
